The available studies indicated, that in cisplatin sensitive human ovarian carcinoma cells (wild-type (WT)), cisplatin-induced osmolyte loss correlates with increased LRRC8A expression, while cisplatin resistance in A2780 RES cells correlates with decreased LRRC8A expression. This evidence concerns the gene LRRC8A and ovarian carcinoma.